A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, ...

Bird flu has decimated poultry flocks and infected cattle herds. The risk to humans is currently low, but that could easily ...

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

While the virus hasn’t made a sustained leap into humans, vaccines and treatments are being developed ahead of an outbreak.

Waterfowl birds and their predators are especially at risk of contracting H5N1. Massachusetts has not yet reported a human ...

According to the Centers for Disease Control and Prevention (CDC), there have been 67 confirmed human cases of H5N1 bird flu ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

In that vein, let's learn about the three most important things you should know if you're going to consider investing in ...

The escalating bird flu crisis is ravaging the nation's egg supply, and that shortage has hit Arizona along with the rest of ...

Last Friday, HHS announced it will provide approximately $590 million to Moderna to accelerate the development of mRNA-based ...

This latest financial support comes on top of the $176 million BARDA gave Moderna last summer. “Avian flu variants have proven to be particularly unpredictable and dangerous to humans in the past.